Investing in the future
Proudly Australian-owned, we believe that continuing to invest in Australia’s healthcare ecosystem is the key to realising genuine value for our communities, patients, pharmacists, prescribers, and partners.
Arrotex offers branded and generic medicines across the spectrum of therapeutic areas. Read more about our approach, our brands, and how we have become the largest provider of prescription medicines in Australia.
Enabling access
Arrotex is dedicated to delivering timely, sustainable, and affordable access to trusted medicines, reliable services, and innovative solutions that enhance the quality of life for all.
We offer the most extensive range of prescription products across the spectrum of therapeutic areas, fulfilling 1 in every 2 PBS scripts in Australia.

Strategic partner of choice
With over 15 years of proven success in representing branded medicines, we have become the Australian partner of choice for multinational pharmaceutical companies seeking to grow and protect their brands.

Licensing innovation
Arrotex is committed to providing access for Australian patients to innovative medicines. Our license partners utilise Arrotex's platform and infrastructure to deliver medicines and health services for the Australian market. As Australia's largest pharmaceutical provider, we offer unprecedented operational and commercial capabilites.

Leading hospital provider
As Australia's leading provider of hospital medicines, Arrotex provides a broad portfolio and range of presentations to public and private hospitals. Our robust supply infrastructure and innovative solutions mean that people can access medicines where and when they are needed most.

In the news
By the numbers
1,298+
Prescription SKUs
Largest
Biologics and biosimilars range
352+
Prescription medicines
18+
Multinational pharmaceutical partnerships
#1
New product launches
200 K+
Patients enrolled in Arrotex SupportEd programs
Our unparalleled access to pharmacists and prescribers enables us to deliver Australia's largest portfolio of branded, generic, and innovative medicines.
Hayley Tamborini
Chief Commercial Officer, Arrotex Pharmaceuticals